about
Capecitabine and temozolomide in grade 1/2 neuroendocrine tumors: a Spanish multicenter experience.Prognostic and diagnostic value of epithelial to mesenchymal transition markers in pulmonary neuroendocrine tumors.Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysisHealth-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors.Hallmarks of gastrointestinal neuroendocrine tumours: implications for treatment.Pembrolizumab for advanced melanoma: experience from the Spanish Expanded Access Program.Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms.Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumoursPrognostic factors in patients with advanced renal cell carcinoma.Impact of erythropoietin on the reduction of blood transfusions and on survival of lung cancer patients receiving first-line chemotherapySnail nuclear expression parallels higher malignancy potential in neuroendocrine lung tumorsPegylated liposomal doxorubicin and gemcitabine in a fixed dose rate infusion for the treatment of patients with poor prognosis of recurrent ovarian cancer: a phase Ib studyPredictive factors for response to treatment in patients with advanced renal cell carcinoma
P50
Q33436462-7DA65475-9C80-460C-9055-A74E617D7A66Q34636822-27978256-EF83-4032-8904-12D3A9677460Q35681825-7E669D27-A661-45B6-8627-E11857E81DEAQ35738251-5A9F3F25-8884-4544-A7DF-2693B337C958Q38258212-2EB8037F-38F9-48C9-BF09-5A2EF3466BA3Q39039083-8B9B02A2-B74B-47BD-B498-E4A203F2531EQ40794876-EC4E093B-E578-427C-BC70-EA16CA57185BQ42315381-0A27378D-E5AC-45AD-A613-E374B5E8241AQ54485432-455CF931-4DFD-40DF-94A2-D9C35EE58A44Q81643128-48169B6A-1BF4-4269-82E6-7028708BD08FQ82585906-CA09C930-6B36-44F5-8E21-990A246F9F20Q83707597-BBE1ED2F-EF54-4121-8E53-479DE5569461Q84241662-BAA55595-5F21-4553-A25C-DC3BAD6D4A74
P50
description
researcher ORCID ID = 0000-0003-1802-4441
@en
name
Guillermo Crespo
@ast
Guillermo Crespo
@en
Guillermo Crespo
@es
Guillermo Crespo
@nl
type
label
Guillermo Crespo
@ast
Guillermo Crespo
@en
Guillermo Crespo
@es
Guillermo Crespo
@nl
prefLabel
Guillermo Crespo
@ast
Guillermo Crespo
@en
Guillermo Crespo
@es
Guillermo Crespo
@nl
P21
P31
P496
0000-0003-1802-4441